Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Attila Strauss Insider Profile
4 Followers
Attila Strauss, Executive at M1 Kliniken AG, holds ― shares in M1 Kliniken AG (Ticker: DE:M12). Most recently, Attila Strauss Sold €575,000 shares of M1 Kliniken AG on Jun 20, 2024 for an estimated value of 12.19M.
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+62.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Attila Strauss does not currently own shares as a corporate insider.
A breakdown of Attila Strauss's holdings
Insider Roles
Executive
Roles that Attila Strauss holds in companies
Most Profitable Insider Trade
The most profitable trade made by Attila Strauss
Attila Strauss's Trading History
List of latest transactions for each holding click on a transaction to see Attila Strauss's performance on stock
You May Also Like
Attila Strauss insider profile FAQ
What is the percentage of profitable transactions made by Attila Strauss?
The percentage of profitable transactions made by Attila Strauss is 100%.
What is the average return per transaction made by Attila Strauss?
The average return per transaction made by Attila Strauss is 62.70%.
What stocks does Attila Strauss hold?
Attila Strauss holds: DE:M12 stocks.
What was Attila Strauss’s latest transaction?
Attila Strauss latest transaction was an Informative Sell of €12.19M.
What was Attila Strauss's most profitable transaction?
Attila Strauss’s most profitable transaction was an Informative Buy of DE:M12 stock on February 2, 2024. The return on the trade was 93.30%.
What is Attila Strauss's role in M1 Kliniken AG?
Attila Strauss's role in M1 Kliniken AG is Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.